Global Depyrogenated Sterile Empty Vials Market to Surpass $ 8 Bn by 2025

February 04, 2020


According to the research report titled ‘Depyrogenated Sterile Empty Vials Market Size By Product (2 ml, 5 ml, 10 ml, 20 ml, More than 20 ml), By End-use (Clinical Labs, Compounding Labs, Pharmaceutical Manufacturers), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Italy, Spain, Netherlands, China, Japan, India, Australia, Brazil, Mexico, Saudi Arabia, South Africa, UAE), Application Potential, Competitive Market Share & Forecast, 2019 – 2025’, available at MarketStudyReport.com, the global depyrogenated sterile empty vials market is expected to cross USD 8 billion by the year 2025.
 

Favorable federal regulations which promote the development of novel packaging for pharmaceutical products is a major factor driving the depyrogenated sterile empty vials industry. Escalating investments by various governments in R&D activities of biopharmaceutical and pharmaceutical companies in order to develop innovative products are also stimulating the industry outlook.
 

Increasing utilization of the product in biological and chemical reactions, sample collection and storage, plant cell culture, and photobiological studies are further aiding the market expansion. There has been an upsurge in diagnostic tests that are conducted in clinical and research labs in order to diagnose infectious diseases which is fostering market growth.
 

Advancements in technology pertaining to vial manufacturing processes along with rising number of infectious diseases are favoring the market outlook.
 

As per product type, vials of more than 20 ml held 28% revenue share of the overall market in the year 2018 and is projected to register a decent growth rate in the approaching years. Rising adoption of such products for packaging processes of injectables along with technological developments in packaging platforms are boosting the growth of the segment. Moreover, increasing number of clinical studies in clinical labs and research institutes are augmenting the demand for the product across the globe.
 

Citing the end-use landscape, pharmaceutical manufacturers segment is expected to grow with a CAGR of 5% during the period of 2019-2025. Increased pervasiveness of diseases along with development of innovative products by pharmaceutical manufacturers are facilitating the business scenario.
 

Request sample copy of this Report@ https://www.marketstudyreport.com/request-a-sample/2100689/
 

As per the regional analysis, North America depyrogenated sterile empty vials industry was worth USD 2.2 billion in the year 2018. Escalating investments by private and public entities, booming biologics market, and advancement in technology in packaging processes of pharmaceuticals are augmenting the regional demand. The popularity of the product is expected to further increase across North America owing to increasing number of clinical labs, rising prevalence of diseases, and flourishing biotechnology and pharmaceutical industries.
 

VWR International, Thermo Fisher Scientific, SGD Pharma, Stevanato Group, Merck KGaA, Radpharm Scientific, Nipro PharmaPackaging, Gerresheimer, DWK Life Sciences, Corning Inc., and APG Pharma are the prominent companies operating in the depyrogenated sterile empty vials industry.


Frequently Asked Questions (FAQ) :

Favorable federal regulations which promote the development of novel packaging for pharmaceutical products is a major factor driving the depyrogenated sterile empty vials industry. Escalating investments by various governments in R&D activities of biopharmaceutical and pharmaceutical companies in order to develop innovative products are also stimulating the industry outlook. Increasing utilization of the product in biological and chemical reactions, sample collection and storage, plant cell culture and photobiological studies are further aiding the market expansion. There has been an upsurge in diagnostic tests that are conducted in clinical and research labs in order to diagnose infectious diseases which is fostering market growth. Advancements in technology pertaining to vial manufacturing processes along with rising number of infectious diseases are favoring the market outlook.
Vials of more than 20 ml held 28% revenue share of the overall market in the year 2018 and is projected to register a decent growth rate in the approaching years. Rising adoption of such products for packaging processes of injectables along with technological developments in packaging platforms are boosting the growth of the segment. Moreover, increasing number of clinical studies in clinical labs and research institutes are augmenting the demand for the product across the globe.
North America depyrogenated sterile empty vials industry was worth USD 2.2 billion in the year 2018. Escalating investments by private and public entities, booming biologics market, and advancement in technology in packaging processes of pharmaceuticals are augmenting the regional demand. The popularity of the product is expected to further increase across North America owing to increasing number of clinical labs, rising prevalence of diseases, and flourishing biotechnology and pharmaceutical industries.
VWR International, Thermo Fisher Scientific, SGD Pharma, Stevanato Group, Merck KGaA, Radpharm Scientific, Nipro PharmaPackaging, Gerresheimer, DWK Life Sciences, Corning Inc., and APG Pharma are the prominent companies operating in the depyrogenated sterile empty vials industry.